New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has ...

Testing was performed using BinaxNOW RSV immunochromatographic assays to detect RSV fusion protein antigen in nasopharyngeal swabs (93% sensitivity, 93% specificity, Alere Scarborough Inc ...

The acquisition focuses on sisunotavir, an RSV fusion inhibitor that UK-based ReViral ... including a follow-up RSV candidate targeting the viral N protein that is in phase 1 testing.

The fusion between Swedish pharmaceutical ... including several different approaches towards Hepatitis C and Respiratory Syncytial Virus (RSV). It was around this point that AZ decided to re ...

Scientists used AI to design a fluorescent protein unlike any seen before. The AI model, ESM3, simulates evolution on a ...

cVeterans Affairs Cooperative Studies Program Clinical Epidemiology Research Center, Veterans Affairs Connecticut Health Care System, West Haven, CT, USA dDepartment of Biostatistics, Yale School of ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.

This narrowing results from swelling caused by a virus. The respiratory syncytial virus (RSV) causes most bronchiolitis. RSV occurs in epidemics almost every winter. People do not develop life-long ...

Dec. 18, 2024 — Scientists have generated human stem cell models which contain notochord -- a tissue in the developing embryo that acts like a navigation system, directing cells where to build ...

There is adjacent ecchymosis (see Figure 1). Etanercept (Enbrel ®) is an injectable fusion protein that competitively inhibits the pro-inflammatory cytokine TNF-α. It is approved for use in ...

Today Early in the fall, experts might also see more cases of respiratory syncytial virus, Dr. Geeta Sood, assistant professor of medicine and epidemiologist at Johns Hopkins Bayview Medical Center, ...